Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis 3-Year Results of a Randomized Controlled Trial

被引:92
作者
Kufner, Sebastian [1 ]
Cassese, Salvatore [1 ]
Valeskini, Marco [1 ]
Neumann, Franz-Josef [2 ]
Schulz-Schuepke, Stefanie [1 ,3 ]
Hoppmann, Petra [4 ]
Fusaro, Massimiliano [1 ]
Schunkert, Heribert [1 ,3 ]
Laugwitz, Karl-Ludwig [3 ,4 ]
Kastrati, Adnan [1 ,3 ]
Byrne, Robert A. [1 ]
机构
[1] Tech Univ Munich, Klin Herz & Kreislauferkrankungen, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany
[2] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 2, Freiburg, Krozingen, Germany
[3] DZHK German Ctr Cardiovasc Res, Munich, Germany
[4] Tech Univ Munich, Med Klin 1, Klinikum Rechts Isar, D-80636 Munich, Germany
关键词
balloon angioplasty; drug-eluting stent restenosis; paclitaxel-eluting balloon; paclitaxel-eluting stent; ISAR-DESIRE; BARE-METAL; ANGIOPLASTY; IMPLANTATION; METAANALYSIS; ANGIOGRAPHY; INSIGHTS;
D O I
10.1016/j.jcin.2015.01.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to investigate the long-term comparative efficacy and safety of paclitaxel-eluting balloon (PEB), paclitaxel-eluting stent (PES), or balloon angioplasty (BA) for the treatment of drug-eluting stent restenosis. BACKGROUND The optimal treatment of drug-eluting stent restenosis remains unknown. Although PEB has shown encouraging results, the long-term clinical efficacy and safety of PEB remains poorly defined. METHODS A total of 402 patients with clinically significant restenosis in limus-eluting stents were randomly assigned to receive PEB (n = 137), PES (n = 131), or BA (n = 134). For this analysis, PEB versus PES and PEB versus BA were compared. The primary efficacy and safety endpoints were target lesion revascularization and the composite of death or myocardial infarction. RESULTS At a median follow-up of 3 years, the risk of target lesion revascularization was comparable with PEB versus PES (hazard ratio [HR]: 1.46, 95% confidence interval [CI]: 0.91 to 2.33; p = 0.11) and lower with PEB versus BA (HR: 0.51, 95% CI: 0.34 to 0.74; p < 0.001). The risk of death/myocardial infarction tended to be lower with PEB versus PES (HR: 0.55, 95% CI: 0.28 to 1.07; p = 0.08), due to a lower risk of death (HR: 0.38, 95% CI: 0.17 to 0.87; p = 0.02). The risk of death/myocardial infarction was similar with PEB versus BA (HR: 0.96, 95% CI: 0.46 to 2.0; p = 0.91). CONCLUSIONS At 3 years, the use of PEB as compared with PES to treat patients with limus-eluting stent restenosis has similar efficacy and safety. PEB remains superior to BA. The sustained efficacy without trade-off in safety supports the role of PEB as treatment option for patients with drug-eluting stent restenosis. (Intracoronary Stenting and Angiographic Results: Drug Eluting Stent In-Stent Restenosis: 3 Treatment Approaches [ISAR-DESIRE 3]; NCT00987324) (C) 2015 by the American College of Cardiology Foundation.
引用
收藏
页码:877 / 884
页数:8
相关论文
共 50 条
[41]   DRUG-ELUTING STENTS: LONG-TERM SAFETY [J].
Karpov, Yu. A. ;
Samko, A. N. ;
Buza, V. V. .
TERAPEVTICHESKII ARKHIV, 2009, 81 (05) :36-41
[42]   Long-Term Outcomes of Zotarolimus-Eluting with Sirolimus-Eluting and Paclitaxel-Eluting Stent in Diabetic Patients: 2-Year Analysis of the ZEST Randomized Trial [J].
Park, Dukwoo ;
Kim, Yoo Ri ;
Sun, Byung Joo ;
Cho, Sung Won ;
Kim, Won-Jang ;
Lee, Jong-Young ;
Kang, Soo-Jin ;
Lee, Seung-Whan ;
Kim, Young-Hak ;
Lee, Cheol Whan ;
Park, Seong-Wook ;
Park, Seung-Jung .
CIRCULATION, 2010, 122 (21)
[43]   Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial [J].
Adriaenssens, Tom ;
Dens, Jo ;
Ughi, Giovanni ;
Bennett, Johan ;
Dubois, Christophe ;
Sinnaeve, Peter ;
Wiyono, Stefanus ;
Coosemans, Mark ;
Belmans, Ann ;
D'hooge, Jan ;
Vrolix, Mathias ;
Desmet, Walter .
EUROINTERVENTION, 2014, 10 (04) :439-448
[44]   In-stent restenosis treatment with seal-wing paclitaxel-eluting balloon catheters [J].
Pleva, Leos ;
Kukla, Pavel ;
Zapletalova, Jana ;
Hlinomaz, Ota .
COR ET VASA, 2021, 63 (04) :442-447
[45]   Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial [J].
Giacoppo, Daniele ;
Alvarez-Covarrubias, Hector A. ;
Koch, Tobias ;
Cassese, Salvatore ;
Xhepa, Erion ;
Kessler, Thorsten ;
Wiebe, Jens ;
Joner, Michael ;
Hochholzer, Willibald ;
Laugwitz, Karl-Ludwig ;
Schunkert, Heribert ;
Kastrati, Adnan ;
Kufner, Sebastian .
EUROPEAN HEART JOURNAL, 2023, 44 (15) :1343-1356
[46]   5-year results of cutting or scoring balloon before drug-eluting balloon to treat in-stent restenosis [J].
Linares Vicente, Jose Antonio ;
Ruiz Arroyo, Jose Ramon ;
Lukic, Antonela ;
Simo Sanchez, Borja ;
Jimenez Melo, Octavio ;
Riano Ondiviela, Adrian ;
Morlanes Gracia, Paula ;
Revilla Marti, Pablo .
REC-INTERVENTIONAL CARDIOLOGY, 2022, 4 (01) :12-18
[47]   Comparison of the Sirolimus-Eluting Versus Paclitaxel-Eluting Coronary Stent in Patients With Diabetes Mellitus: The Diabetes and Drug-Eluting Stent (DiabeDES) Randomized Angiography Trial [J].
Maeng, Michael ;
Jensen, Lisette Okkels ;
Galloe, Anders Michael ;
Thayssen, Per ;
Christiansen, Evald Hoej ;
Hansen, Knud Norregaard ;
Helqvist, Steffen ;
Botker, Hans Erik ;
Lassen, Jens Flensted ;
Thuesen, Leif .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (03) :345-349
[48]   Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent [J].
Li Jian-jun ;
Xu Bo ;
Yang Yue-jin ;
Chen Ji-lin ;
Qiao Shu-bin ;
Ma Wei-hua ;
Qin Xue-wen ;
Yao Min ;
Liu Hai-bo ;
Wu Yong-jian ;
Yuan Jin-qing ;
Chen Jue ;
You Shi-jie ;
Dai Jun ;
Xia Ran ;
Gao Run-lin .
CHINESE MEDICAL JOURNAL, 2007, 120 (07) :569-573
[49]   Drug-eluting stent for the treatment of small coronary lesion:comparison between sirolimus- and paclitaxel-eluting stent [J].
LI Jian-jun XU Bo YANG Yue-Jin CHEN Ji-lin QIAO Shu-bin MA Wei-hua QIN Xue-wen YAO Min LIU Hai-bo WU Yong-jian YUAN Jin-qing CHEN Jue YOU Shi-jie DAI Jun XIA Ran GAO Run-lin Department of Cardiology .
中华医学杂志(英文版), 2007, (07) :569-573
[50]   Paclitaxel-eluting stents for the treatment of femoropopliteal arterial stenoses: focus on the Zilver PTX drug-eluting peripheral stent [J].
Moukarbel, George V. ;
Burket, Mark W. .
EXPERT REVIEW OF MEDICAL DEVICES, 2015, 12 (02) :157-162